ZC3H12A: A Critical Mediator of Inflammation, Tumor Immunotherapy, and Metabolic–Immune Crosstalk—Implications for Disease Treatment
Open Access
- 19 October 2025
- journal article
- review article
- Published by MDPI AG in Biomolecules
- Vol. 15 (10) , 1473
Abstract
ZC3H12A is a key RNA-binding protein and ribonuclease that plays a central role in negatively regulating inflammation and maintaining immune homeostasis. It does this by degrading the mRNA of multiple inflammatory mediators (such as IL-6 and IL-1β), as well as through its deubiquitinating enzyme activity. Not only does it limit excessive immune activation by regulating innate and adaptive immune cells (e.g., macrophages and T cells), but it also exerts bidirectional effects in tumors, acting as an anti-tumor factor to inhibit angiogenesis and oncogenic signal pathways, while promoting tumor progression under specific conditions. In recent years, ZC3H12A has emerged as a critical target for tumor immunotherapy, particularly CAR-T cell therapy. Its knockout significantly enhances T-cell persistence and anti-tumor efficacy, demonstrating broad translational potential. Furthermore, ZC3H12A plays a crucial role in systemic metabolic–immune crosstalk and infectious diseases. This review systematically summarizes the multifunctional roles of ZC3H12A in immune regulation, tumor therapy, metabolic disorders and inflammation-related diseases, with the aim of providing new insights into its potential application in the treatment of human diseases.Keywords
Funding Information
- Fundamental Research Funds for the Central Universities (JYY2023-14)
This publication has 126 references indexed in Scilit:
- The Ribonuclease ZC3H12A is required for self-inflicted DNA breaks after DNA damage in small cell lung cancer cellsCellular Oncology, 2024
- How are MCPIP1 and cytokines mutually regulated in cancer-related immunity?Protein & Cell, 2020
- MCPIP1 inhibits Hepatitis B virus replication by destabilizing viral RNA and negatively regulates the virus-induced innate inflammatory responsesAntiviral Research, 2020
- Integrative genomics reveal a role for MCPIP1 in adipogenesis and adipocyte metabolismCellular and Molecular Life Sciences, 2019
- MCPIP1 regulates RORα expression to protect against liver injury induced by lipopolysaccharide via modulation of miR‐155Journal of Cellular Physiology, 2019
- MCPIP1 inhibits coxsackievirus B3 replication by targeting viral RNA and negatively regulates virus-induced inflammationMedical Microbiology and Immunology, 2017
- MCPIP1 contributes to clear cell renal cell carcinomas developmentAngiogenesis, 2017
- Type I Interferon Inhibition of MicroRNA‐146a Maturation Through Up‐Regulation of Monocyte Chemotactic Protein–Induced Protein 1 in Systemic Lupus ErythematosusArthritis & Rheumatology, 2015
- MCP-1-induced protein-1, an immune regulatorProtein & Cell, 2012
- Post-transcriptional Regulators in Inflammation: Exploring New Avenues in Biological Therapeutics2007